News Snapshot:
By : Yann | Keywords : China, COVID-19, vaccine, Middle East French.china.org.cn | Updated on 26-09-2020 Two inactivated COVID-19 vaccines developed by China National Biotec Group (CNBG), are in phase III clinical trials in the Middle East, with more than 35,000 people inoculated, according to an official from the Ministry of Science and Technology. Chinese vaccine companies have signed cooperation agreements with institutions in several countries, to jointly implement phase III clinical trials in accordance with laws and regulations, said Wu Yuanbin, director of the science department on Friday. and Technology for Social Development Ministry, at a press conference in...
